Medical Ikkou, Mar-May (1Q) Ordinary Profit Increases by 14%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon Jul 7, 2025 3:30 pm JST Earnings

3353 Medical Ikkou Group Co.,Ltd. 【J-GAAP】

Earnings Report

Medical Ikkou Group Co.,Ltd <3353> [TSE Std] announced its financial results after the market closed on July 7th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending February 2026 (March to May) increased 14.2% from the same period last year, reaching 491 million yen. Progress toward the plan for the six months ending August (first half) of 870 million yen was 56.4%, also surpassing the five-year average of 47.7%.

In the most recent three-month period, from March to May (1Q), the operating profit margin worsened from 3.8% in the same period last year to 3.2%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Mar - May, 2023	8,721	294	338	211	56.4	48.6	Jul 3, 2023	J-GAAP
Mar - May, 2024	11,183	429	430	429	114.2	50.4	Jul 8, 2024	J-GAAP
Mar - May, 2025	13,423	434	491	438	116.5	56.4	Jul 7, 2025	J-GAAP
YoY	+20.0%	+1.2%	+14.2%	+2.1%	+2.0%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar - Aug, 2024	22,665	828	853	709	188.8	25	Oct 7, 2024	J-GAAP
Mar - Aug, 2025 Guidance	26,300	900	870	550	146.1	60	Apr 4, 2025	J-GAAP
YoY	+16.0%	+8.7%	+2.0%	-22.4%	-22.6%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2024	39,900	1,559	1,751	1,039	276.7	45	Apr 5, 2024	J-GAAP
Feb, 2025	48,393	1,692	1,816	1,133	301.4	65	Apr 4, 2025	J-GAAP
Feb, 2026 Guidance	52,500	1,950	1,900	1,250	331.9	120	Apr 4, 2025	J-GAAP
YoY	+8.5%	+15.2%	+4.6%	+10.3%	+10.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Mar - May, 2024	11,183	429	430	429	114.2	3.8	Jul 8, 2024	J-GAAP
Jun - Aug, 2024	11,482	399	423	280	74.5	3.5	Oct 7, 2024	J-GAAP
Sep - Nov, 2024	12,425	375	423	290	77.2	3.0	Jan 10, 2025	J-GAAP
Dec - Feb, 2024	13,303	489	540	134	35.6	3.7	Apr 4, 2025	J-GAAP
Mar - May, 2025	13,423	434	491	438	116.5	3.2	Jul 7, 2025	J-GAAP
YoY	+20.0%	+1.2%	+14.2%	+2.1%	+2.0%